BRAF-Mutated Colon Cancer May Be Less Responsive to Aspirin's Positive Effects

An analysis of two colorectal cancer studies found that patients with BRAF mutations were less sensitive to the effects of aspirin as treatment or prevention.
Source: Cancer Network - Category: Cancer & Oncology Source Type: news